Therapeutic approaches to obesity

Bibliography

• KUCZMARSKI RJ, FLEGAL KM, CAMPBELL SM, JOHNSON CL: Increasing prevalence of overweight among US adults. JAMA (1994) 272:205–211.
   PubMed Web of Science ®Google Scholar
• PI-SUNYER FK: Medical hazards of obesity. Ann. Intern. Med. (1993) 119:655-660. JUNG RT: Obesity as a disease. Br. Med. Bull. (1997) 53:307-321. Good general review on obesity. DAVIS R, FAULDS D: Dexfenfluramine. An updated re-view of its therapeutic use in the management of obe-sity. Drugs (1996) 52:696-724. Update on dexfenfluramine as an appetite suppressant.
   Google Scholar
• HANOTIN C, THOMAS F, JONES SP et al.: Efficacy and tol- erability of sibutramine in obese patients: a dose-ranging study. Int. J. Obesity (1998) 22:32–38.
   PubMed Web of Science ®Google Scholar
• •Update on sibutramine as an appetite suppressant.
   Google Scholar
• GIACOBINO JP: 63-adrenoceptor: an update. Eur. J. En- docrinol. (1995) 132:377–385.
   PubMedGoogle Scholar
• SJOSTROM L, RISSANEN A, ANDERSEN T et al.: Random- ised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet (1998) 352:167–172.
   PubMed Web of Science ®Google Scholar
• •Efficacy of orlistat in obese individuals.
   Google Scholar
• ARCH JRS, AINSWORTH AT, CAWTHORNE MA et al.: Atypical 6-adrenoceptor on brown adipocytes as tar-get for anti-obesity drugs. Nature (1984) 309:163–165.
   PubMedGoogle Scholar
• •First description of the atypical (133) receptor and it's possi-ble role in obesity.
   Google Scholar
• KRIEF S, LONNQVIST F, RAIMBAULT S et al: Tissue distri- bution of 63-adrenergic receptor mRNA in man. J. Clin. Invest. (1993) 91:344–349.
   PubMed Web of Science ®Google Scholar
• JEQUIER E, MUNGER R, FELBER JP: Thermogenic effects of various 6-adrenoceptor agonists in humans: their potential usefulness in the treatment of obesity. Am. J. Clin. Nutr. (1992) 55 (Suppl.):249S–251S.
   Google Scholar
• WEISER M, FRISHMAN WH, MICHAELSON D, ABDEEN MA: The pharmacological approach to the treatment of obesity. J. Clin. Pharmacol. (1997) 37:453–473.
   PubMed Web of Science ®Google Scholar
• ••Good review of the pharmacological targets associated withobesity.
   Google Scholar
• BALASUBRAMANIAM AA: Neuropeptide Y family of hor-mones: receptor subtypes and antagonists. Peptides (1997) 18:445–457.
   PubMedGoogle Scholar
• O'SHEA D, MORGAN DG, MEERAN K et al.: Neuropeptide Y induced feeding in the rat is mediated by a novel re-ceptor. Endocrinology (1997) 138:196–202.
   Google Scholar
• ZHANG Y, PROENCA R, MAFFEI M et al.: Positional clon-ing of the mouse obese gene and its human homo-logue. Nature (1994) 372:425–431.
   PubMed Web of Science ®Google Scholar
• ••Original cloning of OB protein (leptin).
   Google Scholar
• TARTAGLIA LA, DEMBSKI M, WENG X et al.: Identifica- tion and expression cloning of a leptin receptor, OB-R. Cell (1995) 83:1263–1271.
   PubMed Web of Science ®Google Scholar
• ••Original cloning of OB protein (leptin) receptor.
   Google Scholar
• COLEMAN D: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabe-tologia (1978) 14:141–148.
   PubMed Web of Science ®Google Scholar
• GWO-HWA L, PROENCA R, MONTEZ JM et al.: Abnormal slicing of the leptin receptor in diabetic mice. Nature (1996) 379:632–635.
   PubMedGoogle Scholar
• CHUA SC, CHUNG WK, WU-PENG S et al.: Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science (1996) 271:994–996.
   PubMed Web of Science ®Google Scholar
• CHEN H, CHARLAT 0, TARTAGLIA LA et al: Evidence that the diabetes gene encodes the leptin receptor: identifi-cation of a mutation in the leptin receptor gene in db/db mice. Cell (1996) 84:491–495.
   PubMed Web of Science ®Google Scholar
• PELLEYMOUNTER MA, CULLEN MJ, BAKER MB et al.: Ef-fects of the obese gene product on body weight regula-tion in ob/ob mice. Science (1995) 269:540–543.
   PubMed Web of Science ®Google Scholar
• HALAAS JL, GAJIWALA KS, MAFFEI M et al.: Weight-reducing effects of the plasma protein encoded by the obese gene. Science (1995) 269:543–546.
   PubMed Web of Science ®Google Scholar
• CAMPFIELD LA, SMITH FJ, GUISEZ Y et al.: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science (1995) 269:546–549.
   PubMed Web of Science ®Google Scholar
• DUNLOP J: CCK receptor antagonists. Gen. Pharmacol (1998) 31:519–524.
   PubMedGoogle Scholar
• BERLAN M, GALITZKY J, TRAN MA, MONTASTRUC P: An-orectic effect of alpha-2 antagonists in dog: effect of acute and chronic treatment. Pharmacol., Biochem. Be-hay. (1991) 39:313–320.
   PubMedGoogle Scholar
• ROBINSON WG, LAVER NM, JACOT JL et al.: Diabetic-like retinopathy ameliorated with the aldose reductase in-hibitor WAY-121,509. Invest. Ophthalmol. Visual ScL (1996) 37:1149–1156.
   PubMedGoogle Scholar
• CONNACHER AA, JUNG RT, MITCHELL PEG: Weight loss in obese subjects on a restricted diet given BRL26830A, a new atypical beta-adrenoceptor agonist. Br. Med. J. Clin. Res. (1988) 296:1217–1220.
   PubMed Web of Science ®Google Scholar
• BLOOM JD, DUTIA MD, JOHNSON BD et al.: CL 316,243. A potent beta-adrenergic agonist virtually specific for beta-3 receptors. A promising antidiabetic and anti-obesity agent. J. Med. Chem. (1992) 35:3081–3084.
   Google Scholar
• WHEELDON NM, MCDEVITT DG, LIPWORTH BJ: Cardiac effects of the beta-3 adrenoceptor agonist BRL35135 in man. Br. J. Clin. Pharmacol. (1994) 37:363–369.
   PubMedGoogle Scholar
• FISHER MH, AMEND AM, BACH TJ et al: A selective hu-man 63 adrenergic receptor agonist increases meta-bolic rate in rhesus monkeys. J. Orin. Invest. (1998) 101:2387–2393.
   PubMed Web of Science ®Google Scholar
• •Addresses species differences in I33-adrenoceptors.
   Google Scholar
• MAFFEI M, HALAAS J, RAVUSSIN E et al: Leptin levels in human and rodent: measurement of plasma leptin and oh RNA in obese and weight reduced subjects. Nature Med. (1995) 1:1155–1161.
   PubMed Web of Science ®Google Scholar
• •Addresses issue of OB protein resistance in obese individuals.
   Google Scholar
• SAKURAI T, AMEMIYA A, ISHII M: Orexins and orexin re- ceptors: a family of hypothalamic neuropeptides and G-protein coupled receptors that regulate feeding be-haviour. Cell (1998) 92:573–585.
   PubMed Web of Science ®Google Scholar
• •Newly identified peptides and their receptors which may be important central regulators of feeding.
   Google Scholar